Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Susana María Sicardi is active.

Publication


Featured researches published by Susana María Sicardi.


Mutation Research\/genetic Toxicology | 1995

Mutagenic activity of isoxazolylnapthoquinoneimines assayed by micronucleus bone marrow test

Susana María Sicardi; Estela Ferrato

Studies were undertaken to evaluate the ability of various quinoneimines to induce micronuclei in bone marrow cells as a measure of their genotoxicity. Accordingly, 2-hydroxy-N-(3,4-dimethyl-5-isoxazolyl)-1,4-naphthoquinone-4-imine (I), its 2-acetyl derivative (II) and 2-[(5-methyl-3-isoxazolyl)amino]-N-(5-methyl-3-isoxazolyl)-1 ,4- naphthoquinone-4-imine (III), as well as two of their precursors, 2-hydroxynaphthoquinone (NQ-2-OH) and 3,4-dimethyl-5-aminoisoxazole (DMAI) were given by intraperitoneal injection at 5, 50, 100 and 200 mg/Kg doses to S.J.L. Swiss mice with 24 h sampling time. Compounds I and II displayed highly significant differences at 50, 100 and 200 mg/kg doses (p < 0.01) and their mutagenic dose response curves correlated closely with an inverted U-shaped form whose interpretation is still the subject of controversy. NQ-2-OH only produced a significant increase in micronucleus frequency at 50 mg/kg, whereas no mutagenic activity was found for compound III and DMAI at the doses assayed. At 50 mg/kg the order of relative mutagenic potencies was I > II > NQ-2-OH. Mechanisms advanced to explain loss of drug activity at high doses include capture saturation, enzymatic induction during metabolism and participation of an independent defense system.


Información tecnológica | 2008

Evaluación del Potencial Mutagénico de Piroxicam, Meloxicam y Precursores mediante el Ensayo de Micronúcleos in vivo

Javier H Gris; Martín A Dragonetti; Beatriz Fernández; Susana María Sicardi

Mutagenic potential of piroxicam (1), 2-aminopyridine (2), meloxicam (3) and 2-amino-5-methylthiazole (4) has been evaluated using in vivo micronucleus test. Four dose levels for each compound were used and bone marrow cells were examined 24 hours after the administration. In the case of the degradation product of piroxicam (2) only 0.1, 0.3, 1.0 and 5.0 mg/kg were evaluated, because at 50 mg/kg all animals died. The results show that doses applied do not induce a statistical significant increase of the frequency of micronucleated polychromatic erythrocytes. Aniline (5) has been used as positive mutagen reference, showing a positive response to the micronucleous induction at doses of 50mg/kg or superior while no induction occur with lower doses. The structural-mutagenic activity relationship between piroxicam and aniline could not been established.


Journal of Pharmaceutical Sciences | 1991

Mutagenic and Analgesic Activities of Aniline Derivatives

Susana María Sicardi; Jorge L. Martiarena; María T. Iglesias


Journal of Heterocyclic Chemistry | 1973

The synthesis and properties of 1,4,5-Benzothiadiazocine derivatives

Susana María Sicardi; Samuel Lamdan; Carlos H. Caozza


Acta Farmacéutica Bonaerense | 1987

Acción clastogénica in vivo de Fenacetina y Paracetamol

Susana María Sicardi; Jorge L. Martiarena; María T. Iglesias


Journal of Medicinal Chemistry | 1970

Synthesis and structure-activity relationships of 1-alkoxyalkyl- and 1-aryloxyalkyl-1,4-benzodiazepin-2-ones.

Samuel Lamdan; Carlos H. Gaozza; Susana María Sicardi; J. A. Izquierdo


Journal of Pharmaceutical Sciences | 1974

New compounds: 4-substituted 5,6-dihydro-2-o-hydroxyphenyl-4h-1,3,4-oxadiazine-5-ones, potential psychopharmacological drugs

Susana María Sicardi; Samuel Lamdan; Carlos H. Gaozza


Journal of Heterocyclic Chemistry | 1999

New 2-substituted 4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides: Spectral and pharmacological properties

Monica Dal Maso; Isabel A. Perillo; Celia B. Schapira; Susana Gorzalczany; María Cristina Dominga Acevedo; Susana María Sicardi


Acta Farmacéutica Bonaerense | 1998

Síntesis, actividad analgésica y antiinflamatoria de análogos del Piroxicam

Monica Dal Maso; Isabel A. Perillo; Celia B. Schapira; Susana Gorzalczany; María Cristina Dominga Acevedo; Susana María Sicardi


Acta farmacéutica bonaerense | 1994

Evaluación del Efecto Genotóxico de Quinonas mediante el Ensayo de Micronúcleos

Estela Ferrato; Margarita Briñón; Susana María Sicardi

Collaboration


Dive into the Susana María Sicardi's collaboration.

Top Co-Authors

Avatar

Samuel Lamdan

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Carlos H. Gaozza

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Celia B. Schapira

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Estela Ferrato

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Isabel A. Perillo

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Monica Dal Maso

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carlos H. Caozza

University of Buenos Aires

View shared research outputs
Researchain Logo
Decentralizing Knowledge